Polen Capital Management Llc released its "Polen Focus Growth Strategy" Q4 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, the Polen Focus Growth strategy delivered a -1 ...

Eli Lilly and Company (NYSE:LLY | LLY Price Prediction) and Novo Nordisk A/S (NYSE:NVO) reported quarterly results in early ...

Eli Lilly's fourth quarter performance was defined by accelerating demand for its obesity and diabetes medicines, as well as rapid uptake in international markets. Management highlighted the strong ...

Mon, February 16, 2026 at 7:00 PM UTC As of February 13, 2026, shares of Eli Lilly (NYSE:LLY) were trading at $1,040, just 5.8% below the stock's all-time high. Retail sentiment has turned decisively ...

Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here. The fund rose 13.10% ...

Eli Lilly (LLY) came out with quarterly earnings of $7.54 per share, beating the Zacks Consensus Estimate of $6.99 per share. This compares to earnings of $5.32 per share a year ago. These figures are ...

A flag flies above the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Lilly, a pharmaceutical company, employs more than 12.000 people in Indianapolis and ...

Eli Lilly and Company LLY announced robust fourth-quarter results on Feb. 4. Lilly beat estimates for both earnings and sales and issued an upbeat guidance for 2026. Adjusted earnings per share of ...

Eli Lilly (LLY) beat Q4 EPS estimates by 12%. Zepbound holds nearly 70% of new obesity prescriptions. Lilly CEO and 12 executives collectively purchased $104M in shares during February. Lilly expects ...